Bentham Science Logo

Track Your Manuscript:


Current Medicinal Chemistry

Volume 27, 42 Issues, 2020
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Meet the Executive Guest Editor(s)

P. Attri
Kyushu University
Fukuoka
(Japan)
Dr. Pankaj Attri, currently working as Associate Professor in Center of Plasma Nano- interface Engineering, Kyushu University, Japan. Dr. Attri has obtained the PhD from the Department of Chemistry, University of Delhi, India in 2013. He worked as Assistant Professor in Department of Electrical and Biological Physics/Plasma Bioscience research center, Kwangwoon University, Seoul, Korea from 2013-2017. Dr. Attri was awarded with Japan Society for the Promotion of Science (JSPS), invitation fellowship (Long term) at Kyushu University, Japan in 2016 and Marie Skłodowska- Curie actions (MSCA) Individual fellowship, at Antwerp University, Belgium from 2017-2019. Dr. Attri, has published 94 articles in peer-reviewed journals with h-index of 33 and total citations over 3400. Four of his articles got featured on cover page of internationally reputed journals. Four of his articles were also selected as Hot article/ Highlights of journal. He also published 8 book chapters with reputed publishers such as Elsevier, Wiley-Scrivener, CRC Press etc, and earned 4 Patents (2 granted and 2 pending). Dr. Attri is also working as Editorial Board Member of Scientific Reports Journal in Chemical Physics panel, Nature publishing Group since 2015 to till date. He also worked as Guest Editor for a special issue “Cold atmospheric plasma activated solution: A new approach for cancer treatment” to be published in Anti-Cancer Agents in Medicinal Chemistry Journal, Bentham Science Publishing Group, Bentham publisher.


R.V. Báez
Canada-University of Toronto
Toronto
(Canada)
Dr. Rodrigo Valenzuela Báez is currently completing his PhD at Department of Nutrition, University of Toronto in Toronto, Canada. He also holds the title of Associate Professor at University of Chile since 2018. His research interest include lipids (fats and oils) in foods and humans nutrition, diet induced obesity and liver steatosis models (rats and mice), cytoprotective effect of bioactive compounds (fats and polyphenols),humans and clinical trials related with the fatty acid metabolism, particularly inpregnancy, young and students, vegetarians, and the elderly and milk and dairy products in human nutrition. Furthermore, his achievements include authoring and co-authoring over 70 articles in peer-reviewed journals and 15 books in diverse topics.


G. Caramori
University of Messina
Messina
(Italy)
Dr. Gaetano Caramori,MD, PhD, is a Full Professor in Respiratory Medicine, at the Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Italy, Head of the Pulmonology Unit at the University Hospital Gaetano Martino of Messina and the Specialisation School in Respiratory Diseases of the University of Messina, Italy (www.unime.it). Gaetano Caramori is, from 2001, Honorary Staff at the Airway Disease Section, National Heart and Lung Institute, Imperial College of London, UK. Dr. Gaetano Caramori has reached an H index=46. He is currently among the 300 Top Italian Scientists & Academics in Clinical Sciences using an independent ranking obtained on the basis of the Google Scholar database (h-index>30 only). He has published 158 articles in International Scientific peer-reviewed indexed Journals, including all the major Journals of the Respiratory System and The New England Journal of Medicine, The Lancet and Nature Medicine.


G. Crisponi
University of Cagliari
Cagliari
(Italy)
Dr. Guido Crisponi took his degree in Chemistry in 1968. Since 1968, he has worked at Cagliari University as “Assistente”, then as “Professore Incaricato”, from 1985 to 2001 as “Professore Associato”, and from 2001 as Full Professor of Analytical Chemistry. The majority of Prof. Crisponi works deal with analytical studies on the distribution of toxic elements in various human tissues, solution equilibria studies on the interaction between metal ions and bio-molecules by potentiometric, spectrophotometric and NMR techniques. In the last twenty years, his research group has been mainly involved in studies concerning chelation therapy to treat the toxic effects of metal ions in humans. He is a member of the Editorial Board of various international journals.


X. Ding
Jiao Tong University
Shanghai
(China)
Dr. Xianting Ding is professor at School of Biomedical Engineering, deputy director of Institute for Personalized Medicine, Shanghai Jiao Tong University. He is elected into the Chinese Top Elite Researcher Program, Qiushi Foundation Elite Young Investigator, Southern California Scientist and Engineering Association Elite Young Researcher. He received his Ph.D. degree from Department of Mechanical Engineering at University of California, Los Angeles (UCLA). His research interests focus on single cell protein analysis and personalized medicine with trace clinical specimens. The technique developed in his lab includes: 1) mass cytometry (also named, CyTOF) technique for single-cell analysis; 2) tissue topology mass spectrometry (in situ single- cell multiplex protein analysis on tissue specimens); 3) portable bio-sensors with microfluidics, bio-electrochemistry, hydrogel and surface modification skills for point-of care technologies(POCT). He participated in the early investigation and development for 3 multi- million-USD international research centers. He is on the editorial board member for Scientific Reports and SLAS Technology (JALA), the reviewer for 20 SCI journals, published 90 peer reviewed SCI papers and filed 30 national or international patents.


Z. Hu
The Ohio State University College of Medicine
Columbus, OH
(USA)
Dr. Zhiwei Hu obtained his PhD in 1997 from Hunan Medical University, Changsha, Hunan, China and then later completed his Post-doctoral in 2000 from the Yale University School of Medicine, New Haven, CT, USA. Currently, he is serving as an Associate Professor at The Ohio State University College of Medicine, USA. Dr. Hu has served as an Editor-in-Chief for prestigious Journals such as Journal of Solid Tumors (6/13/2020), Open Journal of Immunology and The Journal of Analytical & Bioanalytical Techniques. He is also a member of the Overseas Fellow of The Royal Society of Medicine in UK, Member of the Society for ImmunoTherapy of Cancer (SITC), Member of the OSUCCC Translational Therapeutic Program etc. His research interest includes but is not limited to, bioconjugation strategies and medical applications of photodynamic therapy and diagnosis.


H. Lin
University of Electronic Science and Technology of China (UESTC)
Chengdu
(China)
Dr. Hao Lin is a Professor of the Center for Informational Biology at the University of Electronic Science and Technology of China. He received his Ph.D. from Inner Mongolia University, P.R. China in 2007. His researches focused on Bioinformatics and Systems Biology. He has published over 110 peer-reviewed papers in SCI-indexed journals.


K-S. Lin
Yuan Ze University
Taoyuan City
(Taiwan)
Dr. Kuen-Song Lin, is a senior professor of the Department of Chemical Engineering and Materials Science, Yuan Ze University in Taiwan. He is also the Director of Environmental Technology Research Centre (ETRC) and the Dean of Research and Development (R&D office) in Yuan Ze University. His research topics include the waste recycling/reutilization, on-site soil/water pollution remediation, environmental/photocatalytic catalyst preparation technologies, hydrogen storage, carbon capture, and sustainable energy generation. Prof. Lin has published more than 150 articles with citations of more than 3294 (google search on Nov. 29, 2019; High citation Index = 29; i10 index = 68).


M. Pancione
University of Sannio
Benevento
(Italy)
Massimo Pancione received his B.A. degree in Biochemistry from the University of Naples, Federico II, Italy and its Ph.D. degree from the University of Sannio, Benevento, Italy. He worked on the human promoter of the retinol-binding protein as an undergraduate student with Prof. Vittorio Colantuoni in Naples. Later, he completed research training at National Research Council, Avellino, Italy and the Spanish National Cancer Research Center, Madrid, Spain working on mice models of intestinal disease and cancer. He is currently a Researcher of Molecular Biology and Head of the Laboratory of Molecular Oncology and Signal Transduction at the Department of Science and Technology, University of Sannio, Benevento, Italy. In the last years, his research has focused on understanding the molecular mechanisms by which cancer cells of aggressive human tumors grow and remain hidden to metastasize in other organs.


J. Popovic-Djordjevic
University of Belgrade
Belgrade
(Serbia)
Dr. Jelena Popović-Djordjević is a Professor of Organic Chemistry at the University of Belgrade, Faculty of Agriculture (Department for Food Technology and Biochemistry), Belgrade, Serbia. She is a graduate of the University of Belgrade, Faculty of Chemistry, Belgrade, Serbia, where she received her B.A. degree in Chemistry (applied) and her Ph.D. degree in Chemistry (organic) (in 2010). She published over 150 publications, including 40 papers in the leading international peer-reviewed journals, 2 book chapters, and 40 papers on the international and national conferences. Her main research is related to natural product Chemistry, biological activity of natural and synthetic compounds, food chemistry and environmental chemistry. She is a member of the Serbian Chemical Society, the Serbian Water Protection Society, and the Editorial board member in Ecological Safety and Balanced Use of Resources.


C. Savopoulos
Aristotle University of Thessaloniki
Thessaloniki
(Greece)
Dr. Christos Savopoulos received his PhD in 2002 form the Medical School, Aristotle University of Thessaloniki. He currently serves as a Professor of Internal Medicine at the Aristotle University of Thessaloniki. He also serves as the Head of 1st Medical Propaedeutic Department of Internal Medicine at AHEPA University Hospital. He was one of the principal establishers of a Stroke Unit in the University Hospital of AHEPA, Thessaloniki Greece and thereafter the Head of this Stroke Unit. Under his direction this Unit has started to offer thrombolysis treatment and this happened for the first time in this hospital. He is a member of 16 three-member advisory committee of doctoral theses (in the 5 as a supervisor) and he participated in 9 PhD Examination Committees doctoral theses. He is a member of 17 Greek or International Medical Scientific Societies, Associations or Working Groups, in fact founding 4 of them, in 1 of the Board member for 2 consecutive terms in 1 member of audit committee. He has around 140 publications in international journals covered by PubMed & Scopus. His authorship also includes the writing of 27 books or book chapters.


M. Schaffer
Ben-Gurion University of the Negev
Beersheba
(Israel)
Prof. Moshe Schaffer is a Senior Consultant in Barzilai Medical Centre, Dept. of Oncology, affiliated to Faculty of Health Sciences of the Negev, Ben- Gurion University, Israel. He studied Medicine at the University of Padova, Italy, and did his Residency in Radiation Oncology at the University of Goettingen, and the University of Munich, Germany. He has a German and Israeli Board Certificate. He has experience in research and clinical working in Radiation Oncology. The main fields are selective and specific Radiosensitizers, Hyperthermia, and Photodynamic Therapy. Previously, he served as a Deputy Chairman at the Department of Radiation Oncology, University of Munich, Germany. He has a PhD degree from Munich University. Notably, he has authored more than 65 manuscripts, 12 patents, 10 book chapters, and is an Assoc. Editor in 4 scientific Journals. Prof. Schaffer is also an adjunct senior faculty member at the Faculty of Health Sciences, Ben Gurion University, of the Negev, Israel, and teaches Radiation Therapy and Radiation Biology.


X. Shu
Glasgow Caledonian University
Glasgow
(Scotland)
Dr Shu graduated from Hunan Medical University with PhD in Pathobiology (1999) and was then awarded a Wellcome Trust Travelling Fellowship to work at the University of Glasgow (1999-2001), where he worked on the human pathogen Paracoccidioides brasiliensis. From July 2001, he moved to MRC Human Genetics Unit, Edinburgh, to work as an Investigator Scientist (2001-2005) then Senior Investigator Scientist, focusing on the disease mechanisms of retinitis pigmentosa (RP) and age related macular degeneration (AMD). In February 2010 he joined the Department of Biological and Biomedical Sciences, Glasgow Caledonian University, to continue his studies on the pathogenesis of retinal degeneration.


C.P. Soares
State University of São Paulo
Araraquara
(Brazil)
Graduate from the School of Pharmaceutical Sciences, from São Paulo State University (UNESP) in Pharmacy and Biochemistry (1988). Has a Ph.D. in Pathologic Anatomy at Campinas State University’s School of Medicine (UNICAMP) for developing a research of high-risk Human Papillomavirus (HPV), Her first post-doctorate study was accomplished at the University of São Paulo’s School of Medicine of Ribeirão Preto (FMUSP), After that, she was accepted to a second post-doctoral study in Harvard Medical School, Boston, Massachusetts, at the Department of Infectious Diseases, She’s spent all her career investigating therapeutic strategies using natural compounds against cancer development, engaging in a great variety of studies, with an emphasis in head and neck cancer, as well as cervical cancer, all associated to HPV infection. She is, presently, Associated Professor of Cytology and Cellular Biology, at the School of Pharmaceutical Sciences (UNESP). She belongs to an officially recognized excellence post-graduation course in Bioscience and Biotechnology Applied to Pharmacy, according CAPES (Brazilian Scientific Foundation to Research)


T.P. Stanojković
Institute for Oncology and Radiology of Serbia
Belgrade
(Serbia)
Tatjana Stanojković was born in Belgrade on June 26, 1966. She graduated from the Faculty of Biology of the University of Belgrade, Department of Molecular Biology and Physiology. She has been employed at the Institute of Oncology and Radiology of Serbia since 1997, since July 2014, as head of the Department of Biological Response Laboratory, Department of Experimental Oncology. Field of expertise: Experimental oncology, Medicinal Chemistry, in vitro investigation of the anticancer activity of novel synthesized compounds, natural product and marine organisms. Member of the Editorial Board, BMC Complementary and Alternative Medicine since 2012.


J. Troisi
University of Salerno
Salerno
(Italy)
Dr. Jacopo Troisi is Adjunct Professor for Ph.D programme in translational medicine at Salerno University (Italy). He is a research scientist and COO at the European Biomedical Research Institute of Salerno (EBRIS), co-founded by the Harvard University and the Salerno Medical School. He is also co-founder and CEO at Theoreo srl, a spin-off company of the University of Salerno. Dr. Troisi research is related to metabolomics. In particular, he is studying the metabolomic fingerprint of several human disease as a diagnostic tool and as a mechanistic hypothesis generator. He got several international patents and awards for diagnostic tests based on metabolomic profiling.”


C-M. Tzeng
Xiamen University
Xiamen
(China)
Dr. Chi-Meng Tzeng is a full Professor of Pharmaceutical Sciences at Xiamen University, China. He received graduated training in National Tsing- Hua University Nuclear Science School in Radiation Biology, ROC (1989~1993) and Stanford University Medical School in Biochemistry, Microbiology and Immunology USA (1995-2000). Military service as a MD Captain in Tri-Service General Hospital (1993-1995). He was appointed to a principal Investigator in Medical R&D and industrialization at Academic Sinica and National Taiwan University Hospital (2000-2005), conducting fingerprint profiling of adenocarcinoma and herbal medicine through HTS biochips platform technologies. Nowadays, he is fully dedicating in translational medicine among liquid biopsy, microbiota, neoantigen, NGS, -OMICs, immune-cell therapy, AI- big data, herbal medicine and combination theranostics, as well as contributed over 60 SCIs, 4 book chapters, 13 patents and 14 commercial products, IVDs, supplements and medication.


Y-L. Wu
Xiamen University
Xiamen
(China)
Dr. Wu’s current research interests focus on the development of functional polymeric materials for pharmaceutical applications in terms of controllable drug delivery or gene delivery, with over 70 publications on Angew. Chem. Int. Ed., ACS Nano, Adv. Mater., Small, Adv. Healthcare Mater., Biomacromolecules etc and personal H-index of 25 (Google Scholar).


X. Xu
China Pharmaceutical University
Nanjing
(China)
Dr. Xiaowei Xu, Associate Professor in China Pharmaceutical University, Ph.D. in chemical biology and medicinal chemistry. Xu obtained his bachelor degree from University of Science and Technology of China in 2010 and Ph.D. from Wuhan University under the supervision of Prof. Xiang Zhou in 2015. Xu has been published more than twenty articles in international journal such as Nucleic Acids Research, Analytical Chemistry, Bioorganic Chemistry and so on. Xu’s research interests focus on developing new probes for receptors and metabolic enzymes and new drug discovery.


K. Xu
Hubei University of Chinese Medicine
Wuhan
(China)
Kang Xu was born in Wuhan, China in May, 1987. He received his M.M. degree from Hubei University of Chinese Medicine, Wuhan, China and his Ph.D. degree from Chongqing University. He studied stem cell engineering and molecular therapy as a joint Ph.D. student for 2 years in University of California, Berkeley (UCB), and as a junior researcher in University of California, Los Angeles (UCLA). Currently, he is serving as an Associate Professor at the Hubei University of Chinese Medicine. Field of expertise: Chemical based therapeutic mechanism on cardiovascular diseases, in vitro and in vivo investigation of the anti-inflammation activity on arthritis of natural or novel synthesized compounds, wound repair and regeneration, with over 30 publications on Phytotherapy research, Frontiers in Pharmacology, Cell proliferation, Wound repair and regeneration, Pharmaceutical biology and etc., Maximum citations of 20 per one article, as reviewers of Inflammation, Life sciences and etc.


H. Yang
Central South University
Chagsha
(China)
Huaming Yang is a professor in the School of Minerals Processing and Bioengineering at Central South University, China. He completed his Ph.D. at Central South University of Technology in 1998, and went to the University of Bristol as a visiting professor from 2008- 2009. Dr. Yang was elected a leading talent of the National "Ten Thousand Talents Program" in 2016, and awarded the National Science Fund for Distinguished Young Scholars in China in 2012. His research interests involve the synthesis strategy and application of advanced biomedical materials, and the interactions between nanoclay and cell.


P. Zhan
Shandong University
Jinan
(China)
Dr. Peng Zhan is currently working as Associate Professor in Shandong University. In 2012, he was appointed as a JSPS Postdoctoral Fellow in Kyoto Prefectural University of Medicine, Japan. His research area involves discovery of novel antiviral anticancer and neurodegenerative diseases-related agents based on the rational drug design approaches. So far, he has published more than 100I academic papers, more than 20 patents as co-inventor, and received the first prize of Shandong Province Science (2010), CPA-Servier Young Investigator Awards in Medicinal Chemistry (2016), and and many other honors and awards.


K. Zhang
Tongji University School of Medicine
Shanghai
(China)
Prof. Kun Zhang is a Research Fellow and a PhD advisor who comes from Shanghai Tenth Peoples’ Hospital. Nowadays, he is the Deputy Director of Ultrasound Research and Education Institute, Tongji University, School of Medicine. He has published 18 SCI papers as the first author or corresponding author in different journals. He has been chosen as the reviewer of some top journals including Advanced Materials, ACS Nano, Advanced Functional Materials Advanced Sciences, Biomaterials, ACS Applied Materials & Interfaces, and Theranostics. He is also elected as the members or committee members of several academic organizations. He is engaged in molecular imaging and corresponding probe design involving MRI, fluorescence imaging and ultrasound imaging as well as multi-modal imaging, and he is also an expert in immunotherapy, gene editing, tumour microenvironment modulation & monitoring, regenerative medicine, nanomedicine and interdisciplinary research.


Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography
View Full Editorial Board

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

COPE Compliant

Journal History

Current Medicinal Chemistry was introduced in 1994 with the assistance of Dr. Atta-ur-Rahman, who is the current Editor-in-Chief serving since 1994.
Scopus CiteScore Metrics: 3.61

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog